{"url_path":"/sec/bioe/8-k/2026-05-19/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1723059/0001213900-26-058985-index.html","accession_number":"0001213900-26-058985","cik":"0001723059","ticker":"BIOE","issuer_name":"Bio Essence Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1723059/0001213900-26-058985-index.html","primary_entity_key":"0001723059","primary_entity_name":"Bio Essence Corp"},"word_count":104,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits**\n\n** **\n\n**Exhibit No.**\n \n**Description**\n\n99.1\n \n[Consent Resolution and Asset Purchase Agreement](https://www.sec.gov/Archives/edgar/data/1723059/000121390026047207/ea028754801ex99-1.htm)\n\n99.2\n \n[Board of Directors’ Consent Resolution Regarding Assignments](ea029148901ex99-2.htm)\n\n99.3\n \n[Assignment Agreement of Dangwei Zhu](ea029148901ex99-3.htm)\n\n99.4\n \n[Assignment Agreement of Jiahui Zhang](ea029148901ex99-4.htm)\n\n99.5\n \n[Assignment Agreement of Xiaoquiang Cai](ea029148901ex99-5.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1 \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**BIO ESSENCE CORP.**\n\n \n \n\n \n/s/ Yin Yan\n\n \nBy:\nYin Yan\n\n \nIts:\nChief Executive Officer\n\n \nDated: May 19, 2026\n\n \n\n2"}